TrialOpen forum infectious diseases2024

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.

Jennifer Hendrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.